Brigit Biofarmaka Teknologi Tbk. vs Palma Serasih Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Palma Serasih Tbk. trades at Rp198 (market cap 3.75T, 237K 24h volume). The key difference: Palma Serasih Tbk. is far larger — about 21.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 237K). Which is the better fit depends on your goals.
| OBAT | PSGO | |
|---|---|---|
Market Cap | 172.82B | 3.75T |
Volume | 592.2K | 237K |
Lot | 5.92K | 2.37K |
Turnover | 147.05M | 47.03M |
Average Price | 248.31 | 198.42 |
Value | 147.05M | 47.03M |
Indicative Equilibrium Price | 254 | 198 |
Indicative Equilibrium Volume | 10 | 29 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Palma Serasih Tbk (the Company) was established in Jakarta based on Notarial Deed of Besri Zakaria,S.H. No.1 dated June 3, 2008. PT Jalinan kasih Sesama is the parent entity and the ultimate parent entity of the Group.
Read more on PSGO →